《大行報告》花旗微升港燈(02638.HK)目標價至5.45元 去年盈利稍勝預期
花旗發表報告指,在良好成本管控下,港燈-SS(02638.HK)去年股份合訂單位持有人應佔純利按年升6.8%至31.56億元,較市場預期高出4.6%。派第二次中期股息16.09仙,用以代替末期股息。該行預計,美國自今年下半年起減息,公司有望獲估值重評;由於集團75%債務屬定息債,港燈利率風險較低。
考慮資產基礎擴大,該行上調對港燈明年盈測0.7%,且在管制協議下,2024至2028年每年股息率有望持續最少達6.7%,重申予「買入」評級,目標價微升0.9%,由5.4元上調至5.45元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.